BHAWNA SHARMA

Employment

• Gilead Sciences Scientist
  2018 - Present
• Covance Lead Scientist II
  2018 - 2018
• National Cancer Institute Postdoctoral Fellow
  2016 - 2018
• University of Wisconsin-Madison Postdoctoral Fellow
  2013 - 2016

Education

• University of Nebraska Medical Center PhD
  2008 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (9)

• Induction of CXCR2 ligands, stem cell-like phenotype, and metastasis in chemotherapy-resistant breast cancer cells.
  2016 DOI: 10.1016/j.canlet.2015.12.011
  +Save
• ERK-regulated αB-crystallin induction by matrix detachment inhibits anoikis and promotes lung metastasis in vivo.
  2015 DOI: 10.1038/onc.2015.12
  +Save
• Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.
  2015 DOI: 10.1007/s10585-014-9691-0
  +Save
• The efficacy of nuclease-resistant Chol-siRNA in primary breast tumors following complexation with PLL-PEG(5K).
  2013 DOI: 10.1016/j.biomaterials.2013.03.021
  +Save
• Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.
  2013 DOI: 10.1158/1535-7163.MCT-12-0529
  +Save
• Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse.
  2011 DOI: 10.4103/1477-3163.91119
  +Save
• Role of chemokine receptor CXCR2 expression in mammary tumor growth, angiogenesis and metastasis.
  2011 DOI: 10.4103/1477-3163.92308
  +Save
• Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.
  2010 DOI: 10.1517/14728221003652471
  +Save
• CXCL8 and its cognate receptors in melanoma progression and metastasis.
  2010 DOI: 10.2217/fon.09.128
  +Save